Astera Labs, Inc. director Jack R. Lazar reported selling a total of 7,500 shares of common stock in open-market transactions on March 5, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025.
The weighted average sale prices ranged from about $117.64 to $123.50 per share across multiple trades. After these transactions, Lazar directly holds 87,351 shares of Astera Labs common stock.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara reported open-market sales of 10,000 shares of common stock on March 2, 2026. The transactions were carried out in multiple tranches at weighted average prices ranging from about $113.37 to $120.99 per share.
The filing notes that all sales occurred automatically under a pre-established Rule 10b5-1 trading plan adopted on May 29, 2025, which is designed to systematically execute trades over time. Following these sales, Mazzara directly owns 128,084 shares of Astera Labs common stock.
Astera Labs reports rapid expansion and a move to profitability, highlighting both opportunity and risk. Revenue grew from $115.8 million in 2023 to $396.3 million in 2024 and $852.5 million in 2025, while net income reached $219.1 million after prior-year losses. The company focuses on semiconductor-based connectivity for cloud and AI infrastructure, with products like Aries PCIe/CXL retimers, Taurus Ethernet modules, Leo CXL memory controllers, and Scorpio fabric switches, all tied together by its COSMOS software suite. Growth is heavily concentrated: in 2025, one end customer generated more than 70% of revenue and the top three end customers 86%. As of June 30, 2025, non‑affiliate common stock held a $13.2 billion market value at $90.42 per share, and 170,214,503 shares were outstanding on January 31, 2026. Management flags key risks including AI adoption uncertainty, reliance on TSMC and a small set of manufacturing partners, exposure to U.S.–China trade and export controls, cybersecurity threats, and intense competition from larger chipmakers.
Astera Labs, Inc. Chief Executive Officer Mohan Jitendra reported automatic sales of 94,971 shares of common stock on February 17, 2026. The filing states these shares were sold to satisfy tax withholding obligations tied to the vesting of previously granted restricted stock units under a pre-arranged “sell to cover” election, and it notes the transactions were not discretionary trades by the reporting person.
After these sales, Jitendra continues to hold 1,452,739 shares of common stock directly. The filing also reports additional indirect holdings through a living trust and several estate-planning trusts, for which he disclaims beneficial ownership except to the extent of any pecuniary interest.
Astera Labs, Inc. President and COO Gajendra Sanjay reported open-market sales of 94,971 shares of common stock on February 17, 2026. The shares were sold at weighted-average prices between $122.1576 and $126.3400 per share.
According to the disclosure, these shares were required to be sold to satisfy tax withholding obligations tied to vesting and settlement of previously granted restricted stock units, under a pre-arranged “sell to cover” election, and do not represent discretionary trades by Sanjay.
After these sales, he holds 1,531,301 shares directly. Estate-planning trusts associated with him hold an additional 5,864,213 shares in Trust 1, 695,000 shares in Trust 2, and 695,000 shares in Trust 3, for which he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. Chief Financial Officer Michael Truett reported automatic sales of 12,001 shares of common stock on February 17, 2026 to satisfy tax withholding from vested restricted stock units under a pre-arranged sell-to-cover election. Sale prices ranged around $122–$126 per share. Truett continues to hold 192,083 shares directly, while 450,281 additional shares are held by the Tate 1997 Living Trust, for which he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara reported automatic sales of 4,849 shares of common stock on February 17, 2026. The Form 4 notes these open-market sales were made solely to cover tax withholding obligations from vesting restricted stock units. After these transactions, he directly held 138,084 shares of common stock.
Astera Labs, Inc. submitted a Form 144 notice reporting proposed sales of Common Stock tied to the vesting of restricted stock units on 02/15/2026.
The filing lists prior sales by Philip Mazzara: 4,620 shares on 11/17/2025 and 10,000 shares on 01/02/2026. The cover block shows 168,903,616 shares outstanding as of 02/17/2026.
Astera Labs filed a Form 144 disclosing a sale of 11,430 shares of common stock by Michael Truett Tate on 11/17/2025. The filing also records a vesting of restricted stock units on 02/15/2026 and identifies Morgan Stanley Smith Barney LLC as the broker.